Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARS1 | P56192 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | FDFT1 | P37268 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29778284 | 0.84 | MARS1 (0.46) | MARS1LTA4HBCHEKDM4EFDFT1 | |
| SCHEMBL16247086 | 0.84 | ALDH1A1 (0.46) | MARS1BCHEALDH1A1SMN1; SMN2CHRM2 | |
| SCHEMBL16246994 | 0.82 | ACKR3 (0.49) | MARS1BCHEALDH1A1SMN1; SMN2CHRM2 | |
| SCHEMBL16151768 | 0.82 | MC4R (0.54) | LTA4HBCHEKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL16246990 | 0.81 | ALDH1A1 (0.52) | MARS1BCHEKDM4EMAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29778308 | 0.81 | MC4R (0.52) | LTA4HBCHEKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL16435204 | 0.79 | MC4R (0.56) | LTA4HBCHEKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL16429198 | 0.77 | CNR1 (0.46) | MARS1LTA4HKDM4EMAPK1ALDH1A1 | |
| SCHEMBL16247146 | 0.77 | CHRNA1 (0.43) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL22771022 | 0.73 | SCN8A (0.54) | BCHEKDM4EMAPK1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9839219-B2 | Compositions comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | CURZA GLOBAL, LLC | 2016-11-17 | — | — | US | disclosed |
| US-9439433-B2 | Compositions and methods comprising a biocidal polyamine | CURZA GLOBAL, LLC (US) | 2016-09-13 | — | — | US | disclosed |
| US-20150038512-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | THE UNIVERSITY OF UTAH | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMS, SMOX | MARS1 908/4885LTA4H 2604/4885BCHE 589/4885 |
| US-20150038512-A1 | COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMOX, SMS | MARS1 835/4885LTA4H 2411/4885BCHE 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.